Paving the Way for a Novel PAH Treatment: A Collaborative Effort
Pulmonary arterial hypertension (PAH) is a life-threatening disease that predominantly affects women, progressively causing damage to the pulmonary vessels, leading to heart failure. Current treatments are limited, offering only symptomatic relief without addressing the underlying disease. However, a breakthrough is on the horizon, thanks to a multidisciplinary team from Monash University, including the Australian Translational […]
